AngelaTatianaAlistarMD

Oncology • Morristown, NJ

Adjunct Professor,TGen and Medical Director for GIMedical Oncology and Phase 1 program at Morristown Hospital , NJ

Join to view full profile

Dr. Alistar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Alistar's full profile

Already have an account?

Office
Carol G Simon Cancer Center
100 Madison Avenue 2nd Floor
Morristown, NJ 07960

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2009 - 2012
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2009
Iuliu Hatieganu University of Medicine and PharmacyClass of 2001

Certifications & Licensure

NJ State Medical License 2010 - 2025
NC State Medical License 2012 - 2018
NY State Medical License 2009 - 2013
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Asco Virtual Mentoring Program ASCO, 2019
NCMS Board Member North Carolina Medical Society, 2015-2017
NCMS Faculty North Carolina Medical Society, 2015-2017
“Danny Danielson Translation Innovation Award” Hoosier Oncology, 2016
Tinsley R. Harrison Excellence in Teaching Nomination Wake Forest University, 2013, 2015
NCMS Leadership College Nomination NCMS, 2014
Molecular and Translational Oncology Workshop Cancer Education Consortium, 2011
Join now to see all

Clinical Trials

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery Start of enrollment: 2013 May 01
Completed
Phase 1, Phase 2
CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer Start of enrollment: 2013 Apr 01
Completed
Phase 1
Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer Start of enrollment: 2013 May 01
Terminated
Phase 3
CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2013 Jul 01
Completed
Phase 1
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery Start of enrollment: 2015 Jan 06
Completed
Phase 1
A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein Start of enrollment: 2015 Jul 20
Completed
Phase 3
A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2017 Oct 19
Unknown status
Phase 1
Study Evaluating the Ketogenic Diet in Patients With Metastatic Pancreatic Cancer Start of enrollment: 2020 Dec 02
Active, not recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction.
Vincent Chung, Angela Alistar, Carlos Becerra, Anup Kasi, Erkut Borazanci
The Oncologist. 2025-01-17
3 citations
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: ...
Philip A Philip, Vaibhav Sahai, Nathan Bahary, Amit Mahipal, Anup Kasi
Journal of Clinical Oncology. 2024-11-01
44 citations
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial
Bruno Bockorny, Teresa Macarulla, Valerya Semenisty, Erkut Borazanci, Jaime Feliu
Clinical Cancer Research. 2021-09-15

Press Mentions

Atlantic Health System’s Morristown Medical Center Earns National Pancreas Foundation Center DesignationFebruary 21st, 2023
Atlantic Health Presents 7 Studies at Prestigious ASCO MeetingJune 9th, 2021
7 Studies at American Society of Clinical Oncology (ASCO) Annual Meeting Presented by Atlantic Health System Cancer Care Physician ResearchersJune 7th, 2021
Join now to see all

Professional Memberships

American Society of Clinical Oncologists - ASCO
Member

Other Languages

Romanian